Aurinia Pharmaceuticals Inc.·4

Dec 15, 4:09 PM ET

Leversage Jill 4

4 · Aurinia Pharmaceuticals Inc. · Filed Dec 15, 2021

Insider Transaction Report

Form 4
Period: 2021-12-13
Transactions
  • Purchase

    Common Stock

    2021-12-13$20.04/sh+1,600$32,0645,300 total
Footnotes (1)
  • [F1]The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.02 to $20.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Documents

1 file
  • 4
    wf-form4_163960257768858.xmlPrimary

    FORM 4